Literature DB >> 12134853

Are selective COX 2 inhibitors superior to traditional NSAIDs? Pharmacia's response to editorial.

G Steven Geis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12134853

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

1.  Safety profile of celecoxib as used in general practice in England: results of a prescription-event monitoring study.

Authors:  Deborah Layton; Lynda V Wilton; Saad A W Shakir
Journal:  Eur J Clin Pharmacol       Date:  2004-09       Impact factor: 2.953

Review 2.  Do some inhibitors of COX-2 increase the risk of thromboembolic events?: Linking pharmacology with pharmacoepidemiology.

Authors:  David W J Clark; Deborah Layton; Saad A W Shakir
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

3.  Outcome trials of COX-2 selective inhibitors: global safety evaluation does not promise benefits.

Authors:  Jorge Gomez Cerezo; Rubin Lubomirov Hristov; Antonio J Carcas Sansuán; Juan J Vázquez Rodríguez
Journal:  Eur J Clin Pharmacol       Date:  2003-04-16       Impact factor: 2.953

4.  An economic model of long-term use of celecoxib in patients with osteoarthritis.

Authors:  Michael Loyd; Dale Rublee; Philip Jacobs
Journal:  BMC Gastroenterol       Date:  2007-07-04       Impact factor: 3.067
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.